Two recent studies considered whether initiation of second-line therapies in patients already taking metformin for type 2 diabetes occurs too soon or too late.
One recent study examined rates of autism spectrum disorder in children in California, while another in Sweden compared birth defects in infants of mothers with type 1 diabetes and infants of mothers without diabetes.
Older patients with diabetes were the focus of several recent studies, including one that looked at associations between glycemic control and mortality and two that compared second-line medication options.
Mortality and cardiovascular complications from diabetes have gone down, but incidence rates among youth are up, according to recent studies of Swedish and American patients, respectively.
Recent studies assessed the impact of bariatric surgery on diabetes remission, mortality, and health care costs.
Two recent studies analyzed the effects of exercise on glycemic control in patients with type 2 diabetes or impaired glucose tolerance.
Studies published in July looked at factors and conditions associated with variation in glycemic control between clinic visits, including diabetes treatment intensity and Alzheimer's disease.
From the ancient Egyptians to current pilot projects, two recent articles in the New England Journal of Medicine reviewed the history and current state of diabetes care.
Evidence on possible risks of pioglitazone, including bladder cancer, prostate cancer, and fractures, made the news in the past month.
Technological advances that could improve diabetes control in the future made the news in the past month.